Keeping up with Business deals news is key for dealmakers and their advisers. From the latest M&A trends to industry specific analysis, we have you covered.
Despite the uncertainty of the trade war, tariffs, and regulatory policy shifts, deals are being done. A look at the M&A deals that mattered this week:
Pfizer lands a big win with the acquisition of Seagen, a biotech company focused on developing transformative cancer medicines. The acquisition is expected to accelerate its growth targets and strengthen its portfolio in an area of high demand.
The M&A market remains active, albeit with slower growth than in recent years. The first half of 2025 saw a 12% decline in M&A volume and 26% in value. But there was still a healthy mix of sectors involved, with aerospace and defence, chemicals, asset and wealth management, and power and utilities seeing the highest volumes and values.
The M&A market continues to see a rush of private equity-backed deals, as investors look for opportunities to boost their returns. We take a look at some of the most interesting of these.